SF3B1 and neoplasm: Based on the known mutational status of the respective primary tumours, EIF1AX mutations were successfully identified in 6/6 vitreous fluid samples, SF3B1 mutations in 6/8 samples and BAP1 mutations in 5/5 samples (Fig. 2).